130 related articles for article (PubMed ID: 9236900)
21. [Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
Friedrich RE; Krüll A; Schwarz R; Thurmann H; Plambeck K; Schmelzle R
Strahlenther Onkol; 1997 Oct; 173(10):507-12. PubMed ID: 9381359
[TBL] [Abstract][Full Text] [Related]
22. Brachytherapy as part of the conservative treatment for primary and recurrent vulvar carcinoma.
Castelnau-Marchand P; Escande A; Mazeron R; Bentivegna E; Cavalcanti A; Gouy S; Baratiny C; Maroun P; Morice P; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(3):518-525. PubMed ID: 28262516
[TBL] [Abstract][Full Text] [Related]
23. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?
Levendag P; Nijdam W; Noever I; Schmitz P; van de Pol M; Sipkema D; Braat C; de Boer M; Jansen P
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):713-24. PubMed ID: 15183475
[TBL] [Abstract][Full Text] [Related]
24. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of mouth with interstitial iridium-192.
Mazeron JJ; Simon JM; Le Péchoux C; Crook JM; Grimard L; Piedbois P; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1991 May; 21(1):39-47. PubMed ID: 1852918
[TBL] [Abstract][Full Text] [Related]
25. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
[TBL] [Abstract][Full Text] [Related]
26. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
[TBL] [Abstract][Full Text] [Related]
27. [Functional results succeeding primary combined external radiotherapy and brachytherapy for head and neck tumors].
Scheithauer M; Dohr D; Riechelmann H
Laryngorhinootologie; 2002 Oct; 81(10):712-7. PubMed ID: 12397521
[TBL] [Abstract][Full Text] [Related]
28. Epidermoid carcinoma of the anal canal. Results of curative-intent radiation therapy in a series of 270 patients.
Touboul E; Schlienger M; Buffat L; Lefkopoulos D; Pène F; Parc R; Tiret E; Gallot D; Malafosse M; Laugier A
Cancer; 1994 Mar; 73(6):1569-79. PubMed ID: 8156483
[TBL] [Abstract][Full Text] [Related]
29. High dose rate brachytherapy in the treatment of oral cancer--the preliminary one institution experience.
Petera J; Dolezel M; Jirousek Z; Tucek L; Bedrosová J; Frgala T
Neoplasma; 2006; 53(3):232-6. PubMed ID: 16652193
[TBL] [Abstract][Full Text] [Related]
30. Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors.
Chyle V; Zagars GK; Wheeler JA; Wharton JT; Delclos L
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(5):891-905. PubMed ID: 8751398
[TBL] [Abstract][Full Text] [Related]
31. Role of interstitial brachytherapy in oral and oropharyngeal carcinoma: reflection of a series of 1344 patients treated at the time of initial presentation.
Pernot M; Hoffstetter S; Peiffert D; Aletti P; Lapeyre M; Marchal C; Luporsi E; Bey P; Nancy VL
Otolaryngol Head Neck Surg; 1996 Dec; 115(6):519-26. PubMed ID: 8969757
[TBL] [Abstract][Full Text] [Related]
32. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins.
Zelefsky MJ; Harrison LB; Fass DE; Armstrong JG; Shah JP; Strong EW
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):17-21. PubMed ID: 8416876
[TBL] [Abstract][Full Text] [Related]
33. Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma.
González González D; Gouma DJ; Rauws EA; van Gulik TM; Bosma A; Koedooder C
Ann Oncol; 1999; 10 Suppl 4():215-20. PubMed ID: 10436826
[TBL] [Abstract][Full Text] [Related]
34. High-dose-rate interstitial brachytherapy boost in inoperable locally advanced tongue carcinoma.
Santos MA; Guinot JL; Tortajada MI; Santamaría P; Campo V; Oliver L; Peña M; Arribas L
Brachytherapy; 2017; 16(6):1213-1218. PubMed ID: 28807749
[TBL] [Abstract][Full Text] [Related]
35. Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer.
Resch A; Pötter R; Van Limbergen E; Biber E; Klein T; Fellner C; Handl-Zeller L; Langbauer G; Schürer-Waldheim H; Staffen A; Jakesz R; Kubista E; Lehr S; Seitz W
Radiother Oncol; 2002 Apr; 63(1):47-58. PubMed ID: 12065103
[TBL] [Abstract][Full Text] [Related]
36. Cesium-137 needle brachytherapy boosts after external beam irradiation for locally advanced carcinoma of the tongue and floor of the mouth.
Leborgne F; Leborgne JH; Zubizarreta E; Mezzera J
Brachytherapy; 2002; 1(3):126-30. PubMed ID: 15090274
[TBL] [Abstract][Full Text] [Related]
37. Effect of intersource spacing on local control and complications in brachytherapy of mobile tongue and floor of mouth.
Simon JM; Mazeron JJ; Pohar S; Le Péchoux C; Crook JM; Grimard L; Piedbois P; Le Bourgeois JP; Pierquin B
Radiother Oncol; 1993 Jan; 26(1):19-25. PubMed ID: 8438082
[TBL] [Abstract][Full Text] [Related]
38. Early results of pulsed-dose-rate interstitial brachytherapy for head and neck malignancies after limited surgery.
Strnad V; Lotter M; Grabenbauer G; Sauer R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):27-30. PubMed ID: 10656368
[TBL] [Abstract][Full Text] [Related]
39. Clinical evaluation on controlling postoperative recurrence of oral squamous cell carcinoma by intracavity brachytherapy.
Li Y; Li LJ; Zhao HW; Han B; Lang JY
Int J Oral Maxillofac Surg; 2009 Aug; 38(8):840-5. PubMed ID: 19375281
[TBL] [Abstract][Full Text] [Related]
40. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
